For centuries, humanity has been fascinated by the profound effects of certain fungi on the human mind. Among the most well-known are “magic mushrooms,” an informal collective term for species containing the naturally occurring psychedelic substance, psilocybin. These powerful fungi are celebrated, and sometimes feared, for their ability to induce vivid hallucinations, a sense of profound euphoria, and an often-overwhelming feeling of interconnectedness with the world. By subtly yet significantly altering the brain’s visual cortex, psilocybin can distort reality, transforming the mundane into a kaleidoscopic, shimmering pocket dimension teeming with pulsating geometric patterns and altered perceptions of color and form. The journey is often deeply personal, with experiences varying widely from one individual to another, shaped by mood, environment, and dosage.

However, the vast and mysterious world of fungi continues to unveil surprises, challenging our existing understanding of psychoactive compounds. We are now delving into the intriguing case of a lesser-known species, one that offers a remarkably different, and far more specific, type of hallucinatory experience. Originating from the rich biodiversity of China, this particular mushroom, when not prepared with meticulous care by a seasoned chef, has the astonishing ability to conjure visions that are eerily consistent across individuals: countless tiny people.

As the BBC reports, the mushroom in question is *Lanmaoa asiatica*, a species traditionally prized in Chinese cuisine, particularly in the Yunnan province, for its distinctive umami-forward flavor. Yet, beneath its culinary appeal lies a potent secret. In Yunnan, doctors regularly treat hundreds of cases annually where individuals, having consumed improperly prepared *L. asiatica*, experience visions of small, “pint-sized, elf-like figures” seemingly crawling across surfaces, climbing walls, and interacting with their environment. These aren’t abstract patterns or shifting colors; they are distinct, anthropomorphic beings, often described with surprising uniformity.

The cultural awareness of this phenomenon in Yunnan is remarkably widespread, bordering on folklore. University of Utah doctoral candidate in biology, Colin Domnauer, recounted a memorable experience that highlights this local knowledge. “At a mushroom hot pot restaurant there, the server set a timer for 15 minutes and warned us, ‘Don’t eat it until the timer goes off or you might see little people,'” Domnauer told the broadcaster. He further observed, “It seems like very common knowledge in the culture there.” This anecdotal evidence suggests that the hallucinogenic properties of *L. asiatica* are not a newly discovered phenomenon but rather a deeply ingrained part of local tradition and culinary practice, passed down through generations. The precise cooking time is evidently crucial, implying that the active hallucinogenic compounds are either heat-sensitive or require a specific duration of cooking to break down into inert forms.

The hallucinations induced by *Lanmaoa asiatica* are not only specific but also remarkably persistent. Unlike the typical psilocybin trip, which usually runs its course within four to six hours, the visions of tiny people can last an exceptionally long time – up to three days after an initial onset period of 12 to 24 hours. This prolonged duration, combined with the intensity of the experience, frequently necessitates hospitalization for those affected. This is a considerably more severe and enduring ordeal than the average psychedelic journey, underscoring the potent and unique pharmacological profile of *L. asiatica*.

The consistency of these visions across different individuals and cultures is particularly striking. Domnauer, in a November piece for the University of Utah, documented a fascinating account from an elder tribesman in Papua New Guinea, who described seeing “tiny people with mushrooms around their faces. They were teasing him, and he was trying to chase them away.” This suggests a phenomenon that transcends geographical and cultural boundaries, pointing towards a shared neurological mechanism triggered by the mushroom’s compounds. Further reinforcing this consistency, a professor in Yunnan shared his own vivid experience with Domnauer: “When I lifted the tablecloth higher, the heads came off and stuck to the bottom of the cloth and the bodies kept marching in place… I did this many times, at two-minute intervals, and each time they were there, marching and grinning… I measured them, too… they were [one inch] high.” The precision of this description – the size, the behavior, the persistence – highlights the remarkably consistent nature of these “liliputian hallucinations.”

Colin Domnauer’s research is at the forefront of unraveling this mycological mystery. Driven by a profound sense of curiosity, he embarked on a quest to pinpoint the origins of *Lanmaoa asiatica* and, more importantly, to understand the intricate mechanisms by which it affects the human brain to produce such strikingly similar hallucinations across diverse populations. “It sounded so bizarre that there could be a mushroom out there causing fairytale-like visions reported across cultures and time,” he told the BBC. “I was perplexed and driven by curiosity to find out more.” His journey blends traditional ethnomycology with modern neurobiology, seeking to bridge the gap between ancient folklore and cutting-edge science.

The phenomenon of seeing tiny humans after ingesting certain substances is not entirely new to academic literature. These visions have been formally described as “liliputian hallucinations” or “elusive little people,” a nod to Jonathan Swift’s fictional island of Lilliput. However, despite these descriptive terms, the specific compounds responsible for this effect in *L. asiatica* have remained elusive. Even Albert Hofmann, the renowned Swiss chemist credited with the synthesis, self-experimentation, and discovery of lysergic acid diethylamide (LSD), reportedly failed to identify the specific molecules within *L. asiatica* that cause these mysterious hallucinations. This historical context underscores the significant challenge that *L. asiatica* presents to psychopharmacology, suggesting a chemical structure or mechanism of action that is distinctly different from more commonly studied psychedelics.

The mushroom received its formal Latin name in 2015, a relatively recent classification that highlights how much remains unknown about its full spectrum of properties. Domnauer’s research aims to fill these critical gaps in our scientific understanding. His preliminary experiments have already yielded intriguing insights. In controlled studies involving mice, he observed that the animals fell into a profound stupor after being administered extracts of the mushroom, indicating a potent psychoactive effect, though not necessarily a hallucinogenic one in the way humans experience it.

Crucially, Domnauer has definitively determined that *L. asiatica* mushrooms do not contain psilocybin, the primary hallucinogenic compound found in “magic mushrooms.” This finding immediately sets it apart from the more commonly studied psychedelics and suggests an entirely different biochemical pathway for its effects. The main distinguishing characteristic, however, lies in the consistency of the hallucinatory experience. Unlike psilocybin trips, which are highly variable and subjective, influenced by myriad individual factors, the visions induced by *L. asiatica* are remarkably uniform. “The perception of little people is very reliably and repeatedly reported,” Domnauer told the BBC. “I don’t know of anything else that produces such consistent hallucinations.” This consistency presents a unique opportunity for neuroscience to study how specific compounds can reliably trigger such complex and specific visual perceptions in the brain.

Despite his deep involvement in researching this enigmatic fungus, Colin Domnauer has, understandably, yet to ingest the mushroom himself. Given the extraordinarily long duration of the trips – up to three days – and the significant chances of requiring hospitalization due to the intensity and disorientation they can cause, his cautious approach is entirely warranted. Direct human experimentation would carry substantial risks, emphasizing the need for rigorous scientific investigation to isolate and understand the active compounds before any consideration of controlled human studies.

As Domnauer eloquently articulated in his piece for the University of Utah, the mystery of *Lanmaoa asiatica* serves as a powerful reminder of the vast, unexplored wonders within the natural world. “While many questions remain, one thing is for certain: *Lanmaoa asiatica* reminds us that the world of mushrooms, even those found in markets and on dinner plates, conceals mysteries and wonders we’ve yet to imagine.” He concluded with a poignant reflection on the ongoing scientific journey: “Somewhere between traditional folklore and modern biology, between the wild forest floor and the sterile scientific laboratory, lies a story still unfolding, a story that may begin with something as seemingly innocuous as a bowl of mushroom soup.” This sentiment perfectly encapsulates the blend of ancient wisdom and modern scientific inquiry that is slowly, but surely, beginning to peel back the layers of this fascinating fungal enigma.

More on magic mushrooms: Evidence Grows That Tripping on Shrooms Might Increase Your Lifespan